June A. Seymour, CPA, is the Vice President of Finance at Neogene Therapeutics. Before joining Neogene, Ms. Seymour served as the Executive Director of Finance of Autolus Therapeutics PLC, where she oversaw the scaling of the company’s financial operations, SEC reporting, and Sarbanes Oxley compliance. She was an instrumental part of the teams that led three follow-on financings post IPO and the negotiation of the recent financing and co-development agreement with Blackstone.
Previously, Ms. Seymour worked for Ernst & Young LLP for sixteen years, where she was a Senior Manager in the Capital Markets and Assurance practices. She focused on advising her clients in cross border mergers and acquisitions, and IPOs, with a focus on pharmaceutical and biotechnology companies. June earned her B.S. degree in Accounting and Business Administration from the Methodist University in Fayetteville, North Carolina in 2002. She is a Certified Public Accountant in the state of Ohio and a member of the American Institute of Certified Public Accountants (AICPA).
